Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Chirurgia (Bucur) ; 119(2): 211-217, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38743834

ABSTRACT

Introduction: Pelvic organ prolapse is the most frequent and common health problem faced by most patients, representing the descent into the vagina or beyond the introitus of one or more pelvic organs, involving three compartments: anterior-bladder, apical-uterus and posterior-rectus. Lateral hystero/colpopexy is an alternative approach in the repair of symptomatic anterior and apical pelvic prolapse. The main objective is to correct pelvic floor defects, restore anatomy, relieve pressure and maintain normal sexual function. Material and Methods: Surgical intervention was applied to patients with prolapse greater than grade II according to the international prolapse quantification system (POP-Q). For apical, anterior prolapse, the bladder peritoneum is dissected and a polypropylene mesh is fitted to the round ligaments with suspension of the isthmus and cervix and fixation of the mesh with CapSure tacks followed by closure of the vaginal peritoneum. Results: During the performance of the technique I had no intraoperative or postoperative complications. Conservation of the uterus proved to be effective for prolapse correction, significant improvements in patient quality of life, frequency of nocturia, degree of dyspareunia and urgency symptoms were observed. Conclusion: Uterine preservation by lateral hystero/colpopexy is a new, feasible and successful method for treating prolapse.


Subject(s)
Gynecologic Surgical Procedures , Laparoscopy , Pelvic Organ Prolapse , Quality of Life , Surgical Mesh , Humans , Female , Pelvic Organ Prolapse/surgery , Laparoscopy/methods , Treatment Outcome , Gynecologic Surgical Procedures/methods , Middle Aged , Aged , Polypropylenes
2.
Chirurgia (Bucur) ; 119(1): 36-43, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38465714

ABSTRACT

AIM: Clostridium difficile infection is a cause of increased morbidity and mortality in hospitals, particularly in patients with cancer pathology. There are several factors favouring the development of Clostridium difficile infection among cancer patients, including age, exposure to antibiotic and proton pump inhibitors therapy, and chemotherapy. This study was conducted to observe the prevalence of Clostridium difficile infection after the reversal of ileostomy loop for rectal cancer surgery, which were initially operated either open or laparoscopic. METHOD: A retrospective study was performed on patients who were operated in a single surgical team for rectal cancer who benefited of a diverted loop ileostomy over a 4-year period. Results: 23 patients were documented with Clostridium difficile infection out of a total of 63. All 23 patients underwent ileostomy closure later than 3 months after primary surgery, and postoperatively received antibiotic therapy associated with proton pump inhibitors in the first 24 hours. Conclusions: Closure of ileostomy later than 3 months after primary surgery, combined with chemotherapy, antibiotic therapy and proton pump inhibitors, increases the risk of developing Clostridium difficile infection.


Subject(s)
Clostridioides difficile , Clostridium Infections , Rectal Neoplasms , Humans , Ileostomy/adverse effects , Retrospective Studies , Proton Pump Inhibitors , Treatment Outcome , Clostridium Infections/epidemiology , Clostridium Infections/etiology , Rectal Neoplasms/surgery , Rectal Neoplasms/complications , Anti-Bacterial Agents/therapeutic use
3.
Chirurgia (Bucur) ; 118(4): 358-369, 2023 08.
Article in English | MEDLINE | ID: mdl-37697998

ABSTRACT

Background: To prevent surgical site infection (SSI), antibiotic prophylaxis is frequently extended for one day or more following surgery. Post-operative, continuing antibiotic prophylaxis may not be advantageous compared to stopping it right away, as it exposes patients to the hazards of taking antibiotics. Although it is routinely recommended, post-procedural prophylaxis is sometimes not necessary. To optimize the effectiveness of antibiotic prophylaxis (AP) in preventing SSIs, healthcare providers should adhere to evidence-based guidelines, such as those provided by the World Health Organization (WHO) or the American Society of Health-System Pharmacists (ASHP). These guidelines provide recommendations on the appropriate selection, timing, and duration of antibiotic prophylaxis for various surgical procedures. In this literature review we looked if the data available support these recommendations. Methods: We searched PubMed database for articles written between 1st of January 2012 up to 31st of December 2022. We looked at randomized control trials (RCTs) of patients hospitalized in surgical departments, who were given postoperative antibiotic prophylaxis comparing them with those that did not receive it. Results: Out of a total of 566 randomized control trials, 15 were included in this literature review, totalling 11,728 patients. We found indications that in many cases it makes a significant difference in continuing antibiotic prophylaxis postoperatively. However, in some cases, this will result in a similar incidence of post-surgery nosocomial infections between the intervention and control groups. Conclusion: While antibiotic prophylaxis is an important strategy to prevent surgical site infections, the decision to extend antibiotic prophylaxis beyond the intraoperative period should be made on a case-by-case basis and led by guidelines.


Subject(s)
Antibiotic Prophylaxis , Cross Infection , Humans , Treatment Outcome , Anti-Bacterial Agents/therapeutic use , Cross Infection/prevention & control , Databases, Factual , Surgical Wound Infection/prevention & control
4.
Rom J Morphol Embryol ; 61(1): 157-165, 2020.
Article in English | MEDLINE | ID: mdl-32747907

ABSTRACT

Endometriosis (EMs) is a benign disease characterized by the presence of endometrial tissue outside the uterine cavity. EMs associated with ovarian cancer (OC) has a relative low incidence (5% to 10%), sometimes with evidence of a transition stage through atypical EMs (1.6% cases). We have assessed 135 consecutive patients with either EMs or OC and, out of them, our study reports on four cases of ovarian EMs and OC: two cases with endometrioid OC and two cases with high-grade serous OC (HGSOC). Cases with EMs and HGSOC are extremely rarely reported in the literature - we could find not more than 30 cases. The main objective of our research was to observe the possible similarities between EMs and OC. Secondly, we analyzed the differences between EMs associated with endometrioid OC and EMs associated with HGSOC. We evaluated them in terms of clinical status (age, stages of EMs and OC) and immunohistochemical (IHC) expression of estrogen receptor (ER), progesterone receptor (PR), Ki67, p53, p16, Wilms' tumor 1 (WT1), cluster of differentiation (CD) 34 and CD10 immunomarkers - we could not find in the literature all these markers assessed, in the same time, to such samples. Our results indicated that there are no similarities between EMs and OC and no atypical EMs was identified in our cases. We recorded higher values of ER expression in EMs associated with HGSOC than in EMs associated with endometrioid OC. Higher values of ER expression were also recorded in OC than in endometriotic foci. There were no differences in proliferative rate of endometriotic foci associated with endometrioid OC, compared to EMs associated with HGSOC. An aberrant IHC expression for p53 protein and p16 protein was noted only in HGSOC. Also, a positive immunostaining for Wilms' tumor 1 (WT1) was identified only in HGSOC. Higher values of microvessel density were recorded in OC but not in endometriotic foci. We concluded that there were no similarities between EMs and OC for the cases included in our study, but we noticed differences in terms of Ki67 index and also between hormonal receptors expression in EMs associated with HGSOC, comparing with EMs associated with endometrioid OCs. These results may represent a "brick" for future researches on the less understood EMs associated with type II of OCs, especially with HGSOC. Identifying the best marker, which can predict the risk of developing OC for the patients with EMs, may lead to discover new specific therapeutic agents and, therefore, a better, tailored, therapy.


Subject(s)
Endometriosis/complications , Immunohistochemistry/methods , Ovarian Neoplasms/complications , Endometriosis/physiopathology , Female , Humans , Ovarian Neoplasms/physiopathology , Retrospective Studies
5.
JSLS ; 15(1): 77-80, 2011.
Article in English | MEDLINE | ID: mdl-21902948

ABSTRACT

BACKGROUND AND OBJECTIVES: Fascial closure of port sites represents a challenging issue in laparoscopic surgery. The aim of this article is to introduce a procedure that allows the safe suturing of the abdominal fascia in these wounds. METHODS: We herein describe a simple technique for fascial closure after laparoscopy using a transcutaneous approach and standard surgical instruments for suture. RESULTS: The method was used in 34 patients with no intraoperative incidents and no port-site hernias during a mean follow-up of 23.9 months (median 20.5, range 5 to 47). CONCLUSION: The procedure is easy to perform, safe, fast, and inexpensive.


Subject(s)
Laparoscopy/methods , Suture Techniques , Abdomen/surgery , Fasciotomy , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...